Alpha-fetoprotein-concanavalin a binding as a marker to discriminate between germ cell tumours and liver diseases
- 1 December 1995
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (13-14) , 2239-2242
- https://doi.org/10.1016/0959-8049(95)00485-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- False elevations of alpha-fetoprotein associated with liver dysfunction in germ cell tumorsCancer, 1993
- Serum alpha‐fetoprotein and lens culinaris agglutinin‐reactive fraction of alpha‐fetoprotein in patients with hepatocellular carcinomaLiver International, 1993
- Differential lectin reactivities of α-fetoprotein in hepatocellular carcinoma: Diagnostic value when serum α-fetoprotein levels are slightly raisedJournal of Gastroenterology and Hepatology, 1992
- Differential alpha-fetoprotein lectin binding in hepatocellular carcinoma. Diagnostic utility at low serum levelsCancer, 1991
- Alpha-fetoprotein-lectin binding as a marker of tumour activity or liver damageEuropean Journal of Cancer and Clinical Oncology, 1990
- α-fetoprotein: Reevaluation in hepatologyHepatology, 1990
- Serum α-fetoprotein levels and microheterogeneity in patients with different liver diseasesJournal of Hepatology, 1990
- Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditionsGastroenterology, 1990
- Concanavalin A Affinity of Alpha-Fetoprotein: Its Use in Differentiating TumorsAmerican Journal of Clinical Pathology, 1987
- Problems of interpretation of serum concentrations of alpha-foetoprotein (AFP) in patients receiving cytotoxic chemotherapy for malignant germ cell tumoursBritish Journal of Cancer, 1983